Creating siRNA-Based Therapies for Broad Heart Failure Populations

11:30 am - Thursday 28th January 2027

  • Understanding disease-modifying mechanisms of action
  • Recognizing where target identification meets safety profiles
  • GenKardia’s therapeutic position on treating heart failure

Speakers:

Founder and CEO
GenKardia